Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 87, Issue 3, Pages 362-366Publisher
WILEY
DOI: 10.1038/clpt.2009.285
Keywords
-
Categories
Ask authors/readers for more resources
In recent years, drug development has become dramatically globalized, and global clinical trials (GCTs) are being conducted in both International Conference on Harmonisation (ICH) and non-ICH regions. 1 To ensure the success of global drug development, ethnicity-related factors must be taken into consideration. In this article, the experiences and initiatives of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan are described, and the contours of an effective global drug development strategy are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available